Clinical trial
Ovarian Cancer and Immune Response to Flu Vaccine
NCT00478387 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00478387 |
|---|---|
| Title | Ovarian Cancer and Immune Response to Flu Vaccine |
| Official title | Study of the Immunogenicity of Killed Influenza Vaccine in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Remission |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Ovarian Cancer |
| Intervention type | Biological |
| Interventions | The current season's trivalent killed influenza vaccine |
| Enrollment | 37 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | May 24, 2007 |
| Last update posted | Oct 5, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: